Patients w/ history of local hypersensitivity to corticosteroids. Risk factors that may increase systemic absorption of topical steroids. W/draw gradually if manifestations of hypercortisolism (Cushing's syndrome) & reversible hypothalamic-pituitary-adrenal axis suppression are observed. Institute appropriate antimicrobial therapy in case of infection, & w/draw topical corticosteroid if there is spread of infection. Avoid abrupt w/drawal. Reports of visual disturbance. Risk of bacterial infection w/ occlusion. Reports of rebound relapses, development of tolerances, risk of generalised pustular psoriasis & development of local or systemic toxicity when used in psoriasis. Prolonged application to the face is undesirable. If applied to eyelids, ensure that the prep does not enter the eye. Higher occurrence of local hypersensitivity reactions & increased risk of local infection when used for the treatment of dermatitis in chronic leg ulcers. Contains paraffin; avoid smoking or being near an open flame during application & immediately after use. Patients w/ renal or hepatic impairment. Pregnancy & lactation. Long-term continuous therapy should be avoided where possible in infants & childn <12 yr. Elderly.
Sign Out
